Closing prices at the end of each trading day, from 8 Oct 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Revenue | 304.9 | 342.6 | 399.9 |
| Growth | +12.4% | +16.7% | |
| Operating income | −22.2 | −25.8 | −118.6 |
| Net income | −36.9 | −37.4 | −130.9 |
| Growth | |||
| EPS, diluted | −23.04 | −22.72 | −21.96 |
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Gross margin | 12.7% | 13.9% | 13.1% |
| Operating margin | −7.3% | −7.5% | −29.7% |
| Net margin | −12.1% | −10.9% | −32.7% |
| Free cash flow margin | −15.1% | −4.7% | −37.4% |
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Operating cash flow | −45.8 | −16.1 | −148.5 |
| Capital expenditure | −0.1 | −0.0 | −1.0 |
| Free cash flow | −45.9 | −16.2 | −149.5 |
| Growth |
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Cash | 6.7 | 7.7 | 9.6 |
| Total debt | n/a | n/a | 81.8 |
| Net cash (debt) | n/a | n/a | −72.2 |
| Shareholders’ equity | −2,120.1 | −2,263.4 | −454.0 |
In millions of CNY, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2023 31 Dec 2023 | FY2024 31 Dec 2024 | FY2025 31 Dec 2025 |
|---|---|---|---|
| Assets | |||
| 6.7 | 7.7 | 9.6 | |
| n/a | 8.4 | 18.4 | |
| n/a | 9.2 | 8.3 | |
| n/a | 0.5 | 1.2 | |
| n/a | 46.2 | 107.6 | |
| Growth | +132.7% | ||
| Liabilities | |||
| n/a | n/a | 81.8 | |
| calc | n/a | n/a | 81.8 |
| n/a | 545.9 | 588.9 | |
| Equity | |||
| −2,120.1 | −2,263.4 | −2,476.0 | |
| −2,120.1 | −2,263.4 | −454.0 | |
| Growth | |||
| Per share and net cash | |||
| calc | n/a | n/a | −72.2 |
Lines marked calc are worked out here from filed figures; point at one for how. Shown in CNY as filed; the screener converts to dollars.